UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000030972
Receipt number R000035299
Scientific Title Multi-institutional randomized Phase 2 trial of a treatment of nivolumab combined with stereotactic body radiotherapy for patients with unresectable or metastatic renal cell carcinoma.
Date of disclosure of the study information 2018/01/24
Last modified on 2018/01/24 15:39:18

No. Disposal Last modified on Item of update
1 Insert 2018/01/24 13:08:54
2 Update 2018/01/24 15:39:18 Date of protocol fixation